reglab/statecodes huggingface dataset:
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1830 - Authorization for calibration, transmission, and reference sources

Current through Register Vol. 40, No. 24, July 15, 2024
Any person authorized by
						12VAC5-481-1680
						for medical use of radioactive material may receive, possess, and use any of
						the following radioactive material for check, calibration, transmission, and
						reference use:
1. Sealed sources, not
					 exceeding 1.11 GBq (30 mCi) each, manufactured and distributed by a person
					 licensed under
					 12VAC5-481-480
					 or equivalent NRC or other agreement state regulations.
2. Sealed sources, not exceeding 1.11 GBq (30
					 mCi) each, redistributed by a licensee authorized to redistribute the sealed
					 sources manufactured and distributed by a person licensed under
					 12VAC5-481-480
					 or equivalent NRC or other agreement state regulations, providing the
					 redistributed sealed sources are in the original packaging and shielding and
					 are accompanied by the manufacturer's approved instructions.
3. Any radioactive material with a half-life
					 not longer than 120 days in individual amounts not to exceed 0.56 GBq (15
					 mCi).
4. Any radioactive material
					 with a half-life longer than 120 days in individual amounts not to exceed the
					 smaller of 7.4 MBq (200 µCi) or 1000 times the quantities in
					 12VAC5-481-3730.
5. Technetium-99m in amounts as
					 needed.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1840 - Requirements for possession of sealed sources and brachytherapy sources

Current through Register Vol. 40, No. 24, July 15, 2024
A. Licensees in
					 possession of any sealed source or brachytherapy source shall follow the
					 radiation safety and handling instructions supplied by the
					 manufacturer.
B. Licensees in
					 possession of a sealed source shall:
1. Test
					 the source for leakage before its first use unless the licensee has a
					 certificate from the supplied indicating that the source was tested within six
					 months before transfer to the licensee; and
2. Test the source for leakage at intervals
					 not to exceed six months or at other intervals approved by the NRC or another
					 agreement state in the Sealed Source and Device Registry.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1850 - Labeling of vials and syringes

Current through Register Vol. 40, No. 24, July 15, 2024
Each syringe and vial that contains unsealed radioactive
						material shall be labeled to identify the radioactive drug. Each syringe shield
						and vial shield shall also be labeled unless the label on the syringe or vial
						is visible when shielded.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1860 - Surveys of ambient radiation exposure rate

Current through Register Vol. 40, No. 24, July 15, 2024
A. In addition to the surveys required by
					 Part IV (12VAC5-481-600 et seq.)
					 of this chapter, licensees shall survey with a radiation detection survey
					 instrument at the end of each day of use. Licensees shall survey all areas
					 where unsealed radioactive material requiring a written directive was prepared
					 for use or administered.
B.
					 Licensees do not need to perform the surveys required by subsection A of this
					 section in an area where patients or human research subjects are confined when
					 they cannot be released under
					 12VAC5-481-1870.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1870 - Release of individuals containing unsealed radioactive material or implants containing radioactive material

Current through Register Vol. 40, No. 24, July 15, 2024
A.
					 Licensees may authorize the release from its control of any individual who has
					 been administered unsealed radioactive material or implants containing
					 radioactive material if the total effective dose equivalent to any other
					 individual from exposure to the released individual is not likely to exceed 500
					 mrem (5 mSv).
B. Licensees shall
					 provide the released individual, or the individual's parent or guardian, with
					 instructions, including written instructions, on actions recommended to
					 maintain doses to other individuals as low as is reasonable achievable if the
					 total effective dose equivalent to any other individual is likely to exceed 100
					 mrem (1 mSv). If the total effective dose equivalent to a nursing infant or
					 child could exceed 100 mrem (1 mSv), assuming there were no interruption of
					 breast-feeding, the instructions shall also include:
1. Guidance on the interruption or
					 discontinuation of breast-feeding; and
2. Information on the potential consequences,
					 if any, on failure to follow guidance.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1880 - Provision of mobile medical service

Current through Register Vol. 40, No. 24, July 15, 2024
A. The mobile medical service shall be
					 licensed if the service receives, uses, or possesses radioactive material. The
					 client of the mobile medical service shall be licensed if the client receives
					 or possesses radioactive material to be used by a mobile medical
					 service.
B. Licensees providing
					 mobile medical service shall:
1. Obtain a
					 letter signed by the management of each client for whom services are rendered
					 that permits the use of radioactive material at the client's address and
					 clearly delineates the authority and responsibility of the licensee and the
					 client;
2. Inform the client's
					 management who is on site at each client's address of use at the time that
					 radioactive material is being administered;
3. Check instruments used to measure the
					 activity of unsealed radioactive material for proper function before medical
					 use at each client's address or on each day of use, whichever is more frequent.
					 At a minimum, the check for proper function required by this subdivision shall
					 include a constancy check;
4. Check
					 survey instruments for proper operation with a dedicated check source before
					 use at each client's address; and
5. Before leaving a client's address, survey
					 all areas of use for dose rate and removable contamination to ensure compliance
					 with the requirements in Part IV (12VAC5-481-600 et seq.)
					 of this chapter.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 4 - General Technical Requirements › Section 12VAC5-481-1890 - Decay-in-storage

Current through Register Vol. 40, No. 24, July 15, 2024
Licensees may hold radioactive material with a physical
						half-life of less than or equal to 120 days for decay-in-storage before
						disposal without regard to its radioactivity if it:
1. Monitors material at the surface before
					 disposal and determines that its radioactivity cannot be distinguished from the
					 background radiation level with an appropriate radiation detection survey meter
					 set on its most sensitive scale and with no interposed shielding; and
2. Removes or obliterates all radiation
					 labels, except for radiation labels on materials that are within containers and
					 that will be managed as biomedical waste after they have been released from the
					 licensee.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 5 - Unsealed Byproduct Material - Written Directive Not Required › Section 12VAC5-481-1900 - Use of unsealed radioactive material for uptake, dilution, and excretion studies for which a written directive is not required

Current through Register Vol. 40, No. 24, July 15, 2024
Except for quantities that require a written directive
						under
						12VAC5-481-1720,
						licensees may use any unsealed radioactive material prepared for medical use
						for uptake, dilution, or excretion studies that is:
1. Obtained from a manufacturer or preparer
					 licensed under
					 12VAC5-481-480
					 I or equivalent NRC or other agreement state regulations or a PET radioactive
					 drug producer licensed under
					 12VAC5-481-440
					 H or equivalent NRC or other agreement state requirements;
2. Excluding PET radionuclides, prepared by
					 (i) an ANP; (ii) a physician who is an AU and who meets the requirements
					 specified in
					 12VAC5-481-1940
					 or
					 12VAC5-481-1980
					 and
					 12VAC5-481-1940
					 3 a 1; or (iii) an individual under supervision, as specified in
					 12VAC5-481-1710;
3. Obtained from and prepared by an agency,
					 NRC, or another agreement state licensee for use in research in accordance with
					 a Radioactive Drug Research Committee-approved protocol or an Investigation New
					 Drug (IND) protocol accepted by FDA; or
4. Prepared by the licensee for use in
					 research in accordance with a Radioactive Drug Research Committee-approved
					 application or an Investigation New Drug (IND) protocol accepted by FDA for use
					 in research.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 5 - Unsealed Byproduct Material - Written Directive Not Required › Section 12VAC5-481-1910 - Training for uptake, dilution, and excretion studies

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780,
						licensees shall require an authorized user of unsealed radioactive material for
						the uses authorized under
						12VAC5-481-1900
						to be a physician:
1. Who is certified
					 by a medical specialty board whose certification process has been recognized by
					 the NRC, the agency, or an agreement state. The names of board certifications
					 that have been recognized by the NRC or an agreement state are posted on the
					 NRC's Medical Uses Licensee Toolkit Web page. To have its certification process
					 recognized, a specialty board shall require all candidates for certification
					 to:
a. Complete 60 hours of training and
					 experience in basic radionuclide handling techniques and radiation safety
					 applicable to the medical use of unsealed byproduct material for uptake,
					 dilution, and excretion studies as described in subdivisions 3 a (1) through 3
					 a (2) (f) of this section; and
b.
					 Pass an examination administered by diplomates of the specialty board that
					 assesses knowledge and competence in radiation safety, radionuclide handling,
					 and quality control; or
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 5 - Unsealed Byproduct Material - Written Directive Not Required › Section 12VAC5-481-1920 - Use of unsealed radioactive material for imaging and localization studies for which a written directive is not required

Current through Register Vol. 40, No. 24, July 15, 2024
Except for quantities that require a written directive
						under
						12VAC5-481-1720,
						licensees may use any unsealed radioactive material prepared for medical use
						for imaging and localization studies that is:
1. Obtained from a manufacturer or preparer
					 licensed under
					 12VAC5-481-480
					 I or equivalent NRC or other agreement state requirements or a PET radioactive
					 drug producer licensed under
					 12VAC5-481-440
					 H or equivalent NRC or other agreement state requirements;
2. Excluding production of PET radionuclides,
					 prepared by an ANP; a physician who is an authorized user (AU) and who meets
					 the requirements specified in
					 12VAC5-481-1940,
					 or
					 12VAC5-481-1980
					 and
					 12VAC5-481-1940
					 3 a (1) (g); or an individual under the supervision, as specified in
					 12VAC5-481-1710, of
					 an ANP or a physician who is an AU;
3. Obtained from and prepared by an agency,
					 NRC, or another agreement state licensee for use in research in accordance with
					 a Radioactive Drug Research Committee-approved protocol or an IND protocol
					 accepted by FDA; or
4. Prepared by
					 the licensee for use in research in accordance with a Radioactive Drug Research
					 Committee-approved application or an IND protocol accepted by FDA.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 5 - Unsealed Byproduct Material - Written Directive Not Required › Section 12VAC5-481-1930 - Permissible molybdenum-99, strontium-82, and strontium-85 concentrations

Current through Register Vol. 40, No. 24, July 15, 2024
A. Licensees may
					 not administer to humans a radiopharmaceutical that contains:
1. More than 0.15 µCi of molybdenum-99
					 per mCi of technetium-99m (0.15 kBq of molybdenum-99 per MBq of
					 technetium-99m); or
2. More than
					 0.02 µCi of strontium-82 per mCi of rubidium-82 chloride (0.02 kBq of
					 strontium-82 per MBq of rubidium-82 chloride injection) or more than 0.2
					 µCi of strontium-85 per mCi of rubidium-82 (0.2 kBq of strontium-85 per
					 MBq of rubidium-82 chloride injection).
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 5 - Unsealed Byproduct Material - Written Directive Not Required › Section 12VAC5-481-1940 - Training for imaging and localization studies

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780,
						licensees shall require an authorized user (AU) of unsealed radioactive
						material for the uses authorized under
						12VAC5-481-1920
						to be a physician:
1. Who is certified
					 by a medical specialty board whose certification process has been recognized by
					 the NRC, the agency, or an agreement state. The names of board certifications
					 that have been recognized by the NRC or an agreement state are posted on the
					 NRC's Medical Uses Licensee Toolkit Web page; or
2. Who is an AU under
					 12VAC5-481-1980
					 and meets the requirements in subdivision 3 a (2) (g) of this section, or
					 equivalent NRC or other Agreement state requirements; or
3. Who has:
a. Completed 700 hours of training and
					 experience, including a minimum of 80 hours of classroom and laboratory
					 training in basic radionuclide handling techniques applicable to the medical
					 use of unsealed radioactive material for imaging and localization studies. The
					 training and experience shall include at a minimum:
(1) Classroom and laboratory training in the
					 following areas:
(a) Radiation physics and
					 instrumentation;
(b) Radiation
					 protection;
(c) Mathematics
					 pertaining to the use and measurement of radioactivity;
(d) Chemistry of radioactive material for
					 medical use; and
(e) Radiation
					 biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-1950 - Use of unsealed radioactive material for which a written directive is required

Current through Register Vol. 40, No. 24, July 15, 2024
Licensees may use any unsealed radioactive material
						identified in subdivision 2 b (7) of
						12VAC5-481-1980
						prepared for medical use and for which a written directive is required that
						is:
1. Obtained from a manufacturer or
					 preparer licensed under
					 12VAC5-481-480
					 I or equivalent NRC or other Agreement state requirements or a PET radioactive
					 drug producer licensed under
					 12VAC5-481-440
					 H or equivalent NRC or another agreement state requirements;
2. Excluding production of PET radionuclides,
					 prepared by an ANP; a physician who is an authorized user (AU) and who meets
					 the requirements specified in
					 12VAC5-481-1940
					 or
					 12VAC5-481-1980;
					 or an individual under the supervision, as specified in
					 12VAC5-481-1710, of
					 an ANP or the physician who is an AU;
3. Obtained from and prepared by an agency,
					 NRC, or another agreement state licensee for use in research in accordance with
					 an investigational new drug (IND) protocol accepted by U.S. Food and Drug
					 Administration (FDA); or
4.
					 Prepared by the licensee for use in research in accordance with an IND protocol
					 accepted by FDA.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-1960 - Safety instruction

Current through Register Vol. 40, No. 24, July 15, 2024
In addition to the requirements of
						12VAC5-481-2270,
						licensees shall provide radiation safety instruction initially and at least
						annually to personnel caring for patients or human research subjects who cannot
						be released under
						12VAC5-481-1870.
						To satisfy this requirement, the instruction shall be commensurate with the
						duties of the personnel and include:
1. Patient or human research subject
					 control;
2. Visitor control,
					 including:
a. Routine visitation to
					 hospitalized individuals in accordance with
					 12VAC5-481-720
					 A 1; and
b. Visitation authorized
					 in accordance with
					 12VAC5-481-720
					 C;
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-1970 - Safety precautions

Current through Register Vol. 40, No. 24, July 15, 2024
A. For each
					 patient or human research subject who cannot be released under
					 12VAC5-481-1870,
					 licensees shall:
1. Quarter the patient or the
					 human research subject either in:
a. A
					 private room with a private sanitary facility; or
b. A room, with a private sanitary facility,
					 with another individual who also has received therapy with unsealed byproduct
					 material and who also cannot be released under
					 12VAC5-481-1870;
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-1980 - Training for use of unsealed radioactive material for which a written directive is required

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in 12VAC5-481-1780, licensees shall
						require an authorized user (AU) of unsealed radioactive material for the uses
						authorized under 12VAC5-481-1950 to be a physician:
1. Who is certified by a medical specialty
					 board whose certification process has been recognized by the NRC, the agency,
					 or an agreement state and who meets the requirements in subdivision 2 b (7) of
					 this section. The names of board certifications that have been recognized by
					 the NRC or an agreement state are posted on the NRC's Medical Uses Licensee
					 Toolkit Web page; or
2. Who has
					 completed 700 hours of training and experience, including a minimum of 200
					 hours of classroom and laboratory training, in basic radionuclide handling
					 techniques applicable to the medical use of unsealed radioactive material
					 requiring a written directive. The training and experience shall include:
a. Classroom and laboratory training in the
					 following areas:
(1) Radiation physics and
					 instrumentation;
(2) Radiation
					 protection;
(3) Mathematics
					 pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
					 medical use; and
(5) Radiation
					 biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-1990 - Training for the oral administration of sodium iodide (I-131) requiring a written directive in quantities less than or equal to 33 mCi (122 GBq)

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780,
						licensees shall require an authorized user (AU) for the oral administration of
						sodium iodide (I-131) requiring a written directive in quantities less than or
						equal to 33 mCi (1.22 GBq) to be a physician:
1. Who is certified by a medical specialty
					 board whose certification process includes all of the requirements of
					 subdivision 3 of this section and has been recognized by the NRC, the agency,
					 or an agreement state. The names of board certifications that have been
					 recognized by the NRC or an agreement state are posted on the NRC's Medical
					 Licensee Toolkit Web page; or
2.
					 Who is an AU under
					 12VAC5-481-1980
					 for uses listed in subdivision 2 b (7) (a) and (b) of
					 12VAC5-481-1980,
					 12VAC5-481-2000,
					 or equivalent NRC or other agreement state requirements; or
3. Who has:
a. Completed 80 hours of classroom and
					 laboratory training, applicable to the medical use of sodium iodide (I-131) for
					 procedures requiring a written directive. The training shall include:
(1) Radiation physics and
					 instrumentation;
(2) Radiation
					 protection;
(3) Mathematics
					 pertaining to the use and measurement of radioactivity;
(4) Chemistry of byproduct material for
					 medical use; and
(5) Radiation
					 biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-2000 - Training for the oral administration of sodium iodide (I-131) requiring a written directive in quantities greater than 33 mCi (122 GBq)

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780,
						licensees shall require an authorized user (AU) for the oral administration of
						sodium iodide (I-131) requiring a written directive in quantities greater than
						33 mCi (1.22 GBq) to be a physician:
1. Who is certified by a medical specialty
					 board whose certification process includes all of the requirements in
					 subdivision 3 of this section and has been recognized by the NRC, the agency,
					 or an agreement state. The names of board certifications that have been
					 recognized by the NRC or an agreement state are posted on the NRC's Medical
					 Uses Licensee Toolkit Web page; or
2. Who is an AU under
					 12VAC5-481-1980
					 for uses listed in subdivision 2 b (7) (b) of
					 12VAC5-481-1980
					 or equivalent NRC or other agreement state requirements; or
3. Who has:
a. Completed 80 hours of classroom and
					 laboratory training, applicable to the medical use of sodium iodide (I-131) for
					 procedures requiring a written directive. The training shall include:
(1) Radiation physics and
					 instrumentation;
(2) Radiation
					 protection;
(3) Mathematics
					 pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
					 medical use; and
(5) Radiation
					 biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 6 - Unsealed Byproduct Material - Written Directive Required › Section 12VAC5-481-2001 - Training for the parenteral administration of unsealed radioactive material requiring a written directive

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in 12VAC5-481-1780, licensees shall
						require an authorized user (AU) for the parenteral administration requiring a
						written directive to be a physician:
1. Who is an AU under 12VAC5-481-1980 for
					 uses listed in subdivision 2 b (7) (c) of 12VAC5-481-1980 or equivalent NRC or
					 other Agreement state requirements; or
2. Who is an AU under 12VAC5-481-2018,
					 12VAC5-481-2040, or equivalent NRC or other agreement state requirements and
					 who meets the requirements in subdivision 4 of this section; or
3. Who is certified by a medical specialty
					 board whose certification process has been recognized by the NRC, the agency,
					 or an agreement state under 12VAC5-481-2018 or 12VAC5-481-2040 and who meets
					 the requirements in subdivision 4 of this section;
4. Who has:
a. Completed 80 hours of classroom and
					 laboratory training applicable to parenteral administrations. The training
					 shall include:
(1) Radiation physics and
					 instrumentation;
(2) Radiation
					 protection;
(3) Mathematics
					 pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
					 medical use; and
(5) Radiation
					 biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2010 - Use of sources for manual brachytherapy

Current through Register Vol. 40, No. 24, July 15, 2024
Licensees shall use only brachytherapy sources:
1. As approved in the Sealed Source and
					 Device Registry for manual brachytherapy medical use. The manual brachytherapy
					 sources may be used for manual brachytherapy uses that are not explicitly
					 listed in the Sealed Source and Device Registry but must be used in accordance
					 with the radiation safety conditions and limitations described in the Sealed
					 Source and Device Registry; or
2.
					 In research to deliver therapeutic doses for medical use in accordance with an
					 active Investigational Device Exemption application accepted by the U.S. Food
					 and Drug Administration provided the requirements of
					 12VAC5-481-1740
					 are met.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2011 - Surveys after source implant and removal

Current through Register Vol. 40, No. 24, July 15, 2024
A. Immediately after implanting sources in a
					 patient or a human research subject, the licensee shall make a survey to locate
					 and account for all sources that have not been implanted.
B. Immediately after removing the last
					 temporary implant source from a patient or a human research subject, the
					 licensee shall make a survey of the patient or the human research subject with
					 a radiation detection survey instrument to confirm that all sources have been
					 removed.
C. A licensee shall retain
					 a record of the surveys required by subsections A and B of this section in
					 accordance with
					 12VAC5-481-2070
					 O.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2012 - Brachytherapy sources accountability

Current through Register Vol. 40, No. 24, July 15, 2024
A. Licensees shall maintain accountability at
					 all times for all brachytherapy sources in storage or use.
B. As soon as possible after removing sources
					 from a patient or a human research subject, licensees shall return
					 brachytherapy sources to a secure storage area.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2013 - Safety instruction

Current through Register Vol. 40, No. 24, July 15, 2024
A. In
					 addition to the requirements of
					 12VAC5-481-2270,
					 licensees shall provide radiation safety instruction initially and at least
					 annually, to personnel caring for patients or human research subjects who are
					 receiving brachytherapy and cannot be released under
					 12VAC5-481-1870.
B. To satisfy this requirement, the
					 instruction shall be commensurate with the duties of the personnel and include:
1. Size and appearance of the brachytherapy
					 sources;
2. Safe handling and
					 shielding instructions;
3. Patient
					 or human research subject control;
4. Visitor control, including both:
a. Routine visitation of hospitalized
					 individuals in accordance with
					 12VAC5-481-720
					 A 1; and
b. Visitation authorized
					 in accordance with
					 12VAC5-481-720
					 C; and
5. Notification of
					 the RSO, or his designee, and an AU if the patient or the human research
					 subject has a medical emergency or dies. The licensee shall also notify the
					 agency if it is possible that any individual could receive exposures in excess
					 of regulatory limits as a result of the deceased's body.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2014 - Safety precautions

Current through Register Vol. 40, No. 24, July 15, 2024
A. For each
					 patient or human research subject who is receiving brachytherapy and cannot be
					 released under
					 12VAC5-481-1870,
					 licensees shall:
1. Not quarter the patient or
					 human research subject in the same room as an individual who is not receiving
					 brachytherapy;
2. Visibly post the
					 patient's or human research subject's room with a "Radioactive Materials" sign;
					 and
3. Note on the door or in the
					 patient's or human research subject's chart where and how long visitors may
					 stay in the patient's or human research subject's room.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2015 - Calibration measurements of brachytherapy sources

Current through Register Vol. 40, No. 24, July 15, 2024
A. Before the first medical use of a
					 brachytherapy source, licensees shall have:
1. Determined the source output or activity
					 using a dosimetry system that meets the requirements of
					 12VAC5-481-2044;
2. Determined
					 source positioning accuracy with applicators; and
3. Used published protocols currently
					 accepted by nationally recognized bodies to meet the requirements of
					 subdivision 1 and 2 of this subsection.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2016 - Strontium-90 sources for ophthalmic treatments

Current through Register Vol. 40, No. 24, July 15, 2024
A. Licensees who use strontium-90 for
					 ophthalmic treatments must ensure that certain activities as specified in
					 subsection B of this section are performed by either:
1. An authorized medical physicist;
					 or
2. An individual who:
a. Is identified as on ophthalmic physicist
					 on a specific medical use license issued the agency, NRC, or another agreement
					 state; permit issued by an agency, NRC, or another agreement state broad scope
					 licensee; medical use permit issued by a NRC master material licensee; or
					 permit issued by a NRC master material broad scope medical use
					 permittee;
b. Holds a master's or
					 doctor's degree in physics, medical physics, other physical sciences,
					 engineering, or applied mathematics from an accredited college or
					 university;
c. Has successfully
					 completed one year of full-time training in medical physics and an additional
					 year of full-time work experience under the supervision of a medical physicist;
					 and
d. Has documented training in
					 the following:
(1) The creation, modification,
					 and completion of written directives;
(2) Procedures for administrations requiring
					 a written directive; and
(3)
					 Performing the calibration measurements of brachytherapy sources as detailed in
					 12VAC5-481-2015.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2017 - Therapy-related computer systems

Current through Register Vol. 40, No. 24, July 15, 2024
Licensees shall perform acceptance testing on the
						treatment planning system of therapy-related computer systems in accordance
						with published protocols accepted by nationally recognized bodies. At a
						minimum, the acceptance testing shall include, as applicable, verification
						of:
1. The source-specific input
					 parameters required by the dose calculation algorithm;
2. The accuracy of dose, dwell time, and
					 treatment time calculations at representative points;
3. The accuracy of isodose plots and graphic
					 displays; and
4. The accuracy of
					 the software used to determine sealed source positions from radiographic
					 images.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2018 - Training for use of manual brachytherapy sources

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780, licensees shall
						require an authorized user of a manual brachytherapy source for uses authorized
						under 12VAC5-481-2010 to be a
						physician:
1. Who is certified by a
					 medical specialty board whose certification process has been recognized by the
					 NRC, the agency, or an agreement state. The names of board certifications that
					 have been recognized by the NRC or an agreement state are posted on the NRC's
					 Medical Uses Licensee Toolkit Web page. To have its certification process
					 recognized, a specialty board shall require all candidates for certification
					 to:
a. Successfully complete a minimum of
					 three years of residency training in a radiation oncology program approved by
					 the Residency Review Committee of the Accreditation Council for Graduate
					 Medical Education or the Royal College of Physicians and Surgeons of Canada or
					 the Council on Postdoctoral Training of the American Osteopathic Association;
					 and
b. Pass an examination
					 administered by diplomates of the specialty board that tests knowledge and
					 competence in radiation safety, radionuclide handling, treatment planning,
					 quality assurance, and clinical use of manual brachytherapy; or
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 7 - Manual Brachytherapy › Section 12VAC5-481-2019 - Training for ophthalmic use of strontium-90

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided in
						12VAC5-481-1780,
						licensees shall require the AU of strontium-90 for ophthalmic radiotherapy to
						be a physician:
1. Who is an
					 authorized user (AU) under
					 12VAC5-481-2018
					 or equivalent NRC or other Agreement state requirements; or
2. Who has:
a. Completed 24 hours of classroom and
					 laboratory training applicable to the medical use of strontium-90 for
					 ophthalmic radiotherapy. The training shall include:
(1) Radiation physics and
					 instrumentation;
(2) Radiation
					 protection;
(3) Mathematics
					 pertaining to the use and measurement of radioactivity; and
(4) Radiation biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 8 - Sealed Sources for Diagnosis › Section 12VAC5-481-2020 - Use of sealed sources for diagnosis

Current through Register Vol. 40, No. 24, July 15, 2024
A. Licensees shall use only sealed sources
					 that are not in medical devices for diagnostic medical uses if the sealed
					 sources are approved in the Sealed Source and Device Registry but must be used
					 in accordance with the radiation safety conditions and limitations described in
					 the Sealed Source and Device Registry.
B. A licensee must only use medical devices
					 containing sealed sources for diagnostic medical uses if both the sealed
					 sources and medical devices are approved in the Sealed Source and Device
					 Registry for diagnostic medical uses. The diagnostic medical devices may be
					 used for diagnostic medical uses that are not explicitly listed in the Sealed
					 Source and Device Registry but must be used in accordance with the radiation
					 safety conditions and limitations described in the Sealed Source and Device
					 Registry.
C. Sealed sources and
					 devices for diagnostic medical uses may be used in research in accordance with
					 an active Investigational Device Exemption application accepted by the U.S.
					 Food and Drug Administration provided the requirements of
					 12VAC5-481-1740
					 are met.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 8 - Sealed Sources for Diagnosis › Section 12VAC5-481-2030 - Training for use of sealed sources for diagnosis

Current through Register Vol. 40, No. 24, July 15, 2024
Except as provided by
						12VAC5-481-1780,
						licensees shall require the authorized user of a diagnostic sealed source for
						use in a device authorized under
						12VAC5-481-2020
						to be a physician, dentist, or podiatrist who:
1. Is certified by a specialty board whose
					 certification process includes all of the requirements in subdivisions 3 and 4
					 of this section and whose certification has been recognized by the NRC, the
					 agency, or an agreement state. The names of board certifications that have been
					 recognized by the NRC or an agreement state are posted on the NRC's Medical
					 Uses Licensee Toolkit Web page; or
2. Is an authorized user for uses listed
					 under
					 12VAC5-481-1920
					 or equivalent NRC or other agreement state requirements; or
3. Has completed eight hours of classroom and
					 laboratory training in basic radionuclide handling techniques specifically
					 applicable to the use of the device. The training shall include:
a. Radiation physics and
					 instrumentation;
b. Radiation
					 protection;
c. Mathematics
					 pertaining to the use and measurement of radioactivity; and
d. Radiation biology; and
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 9 - Photon Emitting Remote Afterloader Units, Teletherapy Units, and Stereotactic Radiosurgery Units › Section 12VAC5-481-2040 - Training requirements and use of a sealed source in a remote afterloader unit, teletherapy unit, or gamma stereotactic radiosurgery unit

Current through Register Vol. 40, No. 24, July 15, 2024
A. Except
					 as provided in
					 12VAC5-481-1780, licensees shall
					 require an authorized user (AU) of a sealed source in remote afterloader units,
					 teletherapy units, and gamma stereotactic radiosurgery units to be a physician:
1. Who is certified by a medical specialty
					 board whose certification process has been recognized by the NRC, the agency,
					 or an agreement state and who meets the requirements in subdivision 4 of this
					 section. The names of board certifications that have been recognized by the
					 agency, NRC, or an agreement state are posted on the NRC's Medical Uses
					 Licensee Toolkit Web page. To have its certification process recognized, a
					 specialty board shall require all candidates for certification to:
a. Successfully complete a minimum of three
					 years of residency training in a radiation therapy program approved by the
					 Residency Review Committee of the Accreditation Council for Graduate Medical
					 Education or the Royal College of Physicians and Surgeons of Canada or the
					 Council on Postdoctoral Training of the American Osteopathic Association;
					 and
b. Pass an examination
					 administered by diplomates of the specialty board that tests knowledge and
					 competence radiation safety, radionuclide handling, treatment planning, quality
					 assurance, and clinical use of stereotactic radiosurgery, remote afterloaders
					 and external beam therapy; or
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 9 - Photon Emitting Remote Afterloader Units, Teletherapy Units, and Stereotactic Radiosurgery Units › Section 12VAC5-481-2041 - Surveys required

Current through Register Vol. 40, No. 24, July 15, 2024
A.
					 Radiation surveys.
1. In addition to the
					 survey requirements in
					 12VAC5-481-750, licensees
					 shall make surveys to ensure that the maximum radiation levels and average
					 radiation levels from the surface of the main source safe with the source in
					 the shielded position do not exceed the levels stated in the Sealed Source and
					 Device Registry.
2. The licensee
					 shall make the survey required by subdivision 1 of this subsection at
					 installation of a new source and following repairs to the source shielding, the
					 source driving unit, or other electronic or mechanical component that could
					 expose the source, reduce the shielding around the source, or compromise the
					 radiation safety of the unit or the source.
Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 481 - VIRGINIA RADIATION PROTECTION REGULATIONS › Part VII - Use of Radionuclides in the Healing Arts › Article 9 - Photon Emitting Remote Afterloader Units, Teletherapy Units, and Stereotactic Radiosurgery Units › Section 12VAC5-481-2042 - Installation, maintenance, adjustment, and repair

Current through Register Vol. 40, No. 24, July 15, 2024
A. Only a person specifically licensed by the
					 agency, the NRC, or another agreement state shall install, maintain, adjust, or
					 repair a remote afterloader unit, teletherapy unit, or gamma stereotactic
					 radiosurgery unit that involves work on the source shielding, the source
					 driving unit, or other electronic or mechanical components that could expose
					 the source, reduce the shielding around the source, or compromise the radiation
					 safety of the unit or the source.
B. Except for low dose-rate remove
					 afterloader unit, only a person specifically licensed by the agency, the NRC,
					 or another agreement state shall install, replace, relocate, or remove a sealed
					 source or source contained in other remote afterloader units, teletherapy
					 units, or gamma stereotactic radiosurgery units.
C. For a low dose-rate remote afterloader
					 unit, only a person specifically licensed by the agency, the NRC, or another
					 agreement state or an authorized medical physicist shall install, replace,
					 relocate, or remove a sealed source contained in the unit.
Statutory Authority: §
													32.1-229
						  of the Code of Virginia.